Devices and methods for interstitial injection of biologic agents into tissue

• US 7,628,780 B2
• Filed: 11/30/2004
• Issued: 12/08/2009
• Est. Priority Date: 01/13/2001
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Hiniduma-Lokuge, Prasanga D., Rothstein, Paul T., Keogh, James R., Usher, Raymond W., Bonner, Matthew D., Chen, Victor T., Jahns, Scott Eric
• Primary Examiner(s): Lucchesi; Nicholas D
• Assistant Examiner(s): HOLLOWAY, IAN KNOBEL
• Application Number:
  US11/000,798
• Publication Number:
  US 20050209564A1
• Time in Patent Office: 1,834 Days
• Field of Search: 604/173, 604/506, 600/37
• US Class Current: 604/500
• CPC Class Codes: A61B 17/00234 for minimally invasive surgery A61B17/0218, A61B17/0469, A61B17/12013, A61B17/1285, A61B17/29, A61B17/320016 take precedence
• CPC Class Codes: A61B 17/205 Vaccinating by means of needles or other puncturing devices
• CPC Class Codes: A61B 17/3478 Endoscopic needles, e.g. for infusion biopsy needles A61B10/0233; catheters with injection needles A61M25/0067
• CPC Class Codes: A61B 2017/00243 cardiac
• CPC Class Codes: A61B 2017/00247 Making holes in the wall of the heart, e.g. laser Myocardial revascularization
• CPC Class Codes: A61B 2017/2926 Details of heads or jaws
• CPC Class Codes: A61B 2017/2936 Pins in guiding slots
• CPC Class Codes: A61B 2017/2943 Toothed members, e.g. rack and pinion
• CPC Class Codes: A61B 2017/306 holding by means of suction
• CPC Class Codes: A61B 2018/00392 Transmyocardial revascularisation
• CPC Class Codes: A61B 2090/034 abutting on parts of the device itself
• CPC Class Codes: A61M 25/0084 being one or more injection needles

Abstract

Apparatus and methods for injecting biological agents into tissue. Devices are provided having elongate shafts and distal injection heads for driving needles into tissue and injecting medical agents into the tissue through the needles. A longitudinal force directed along the shaft can be translated to a needle driving force. Some devices provide controllably variable needle penetration depth. Devices include mechanical needle drivers utilizing four link pantographs, rack and pinions, and drive yokes for driving a first needle bearing body toward a second tissue contacting body. Other devices include inflatable members for driving and retracting needles. Still other devices include magnets for biasing the needles in extended and/or retracted positions. The invention includes minimally invasive methods for epicardially injecting cardiocyte precursor cells into infarct myocardial tissue.

Claims

1. A method for epicardially injecting a substance into an area of tissue of a heart having an epicardial surface and disposed within a torso, the method comprising:

providing a substance-injecting device including

a suction member comprising a suction pad comprising a plurality of suction ports,

a plurality of needles slidably coupled to the suction member,

an elongate shaft having a longitudinal axis, a proximal region, a distal region, and

a needle driver coupled to the elongate shaft distal region for driving the needles substantially parallel to the elongate shaft distal region longitudinal axis through the suction member and into tissue;

making an opening into the torso;

advancing the injecting device through the opening to the epicardial surface of the heart;

grasping an area of tissue of the heart via the suction member;

driving the needles into the area of tissue grasped by the suction member; and

injecting the substance from the device into the area of tissue grasped by the suction member.

2. A method as in claim 1, wherein the making opening step includes making an intercostal opening.

3. A method as in claim 1, wherein the making opening step includes making a xiphoid opening below the sternum.

4. A method as in claim 1, wherein the injecting the substance step includes injecting a substance selected from the group consisting of bone marrow cells, stem cells, embryonic stem cells, pluripotent stem cells, mesenchymal stem cells, and satellite muscle cells.

5. A method as in claim 1, wherein the injecting the substance step includes injecting a substance selected from the group consisting of growth factors, vascular endothelial growth factors, and angiogenesis promoting agents.

6. A method as in claim 1, wherein the making opening step includes making a sternotomy.

7. A method as in claim 1, further comprising the step of sensing contractions of the heart.

8. A method as in claim 7, wherein the injecting the substance step occurs between contractions of the heart.

9. A method as in claim 8, wherein the heart is temporarily stopped using vagal nerve stimulation.

10. A method as in claim 1, further comprising:

providing a suction assisted positioning device;

engaging the heart with the positioning device; and

,

positioning the heart into a non-physiological orientation.

11. A method as in claim 10, wherein the injecting the substance step occurs following the positioning of the heart in a non-physiological orientation step.

12. A method as in claim 1, wherein the injecting the substance step includes injecting a substance selected from the group consisting of platelet rich plasma, platelet poor plasma, fibrinogen and a clotting agent.

13. A method as in claim 12, wherein the clotting agent is thrombin.